TheraSphere HUD For Treatment of Unresectable Hepatocellular Carcinoma (HCC)

This study has been completed.
Sponsor:
Collaborator:
MDS Pharma Services
Information provided by (Responsible Party):
Robert C. Martin, University of Louisville
ClinicalTrials.gov Identifier:
NCT00683631
First received: May 16, 2008
Last updated: October 18, 2013
Last verified: October 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2012
  Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)
No publications provided by University of Louisville

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):